Effects of Dietary Fucoxanthin on Cholesterol Metabolism in Diabetic/obese KK-A(y) Mice

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2012 Sep 12

PMID 22962999

Citations 23

Authors

Fumiaki Beppu

Masashi Hosokawa

Yoshimi Niwano

Kazuo Miyashita

Affiliations

Soon will be listed here.

Abstract

Background: Fucoxanthin is a xanthophyll present in brown seaweeds and has several beneficial effects, including anti-obesity and anti-diabetic effects. However, we and another group previously observed that fucoxanthin increases serum cholesterol levels in rodents. Cholesterol is an important component of cell membranes and biosynthesis of bile acids. Serum cholesterol levels are also closely associated with atherosclerosis. Therefore, we sought to identify the mechanism underlying the increase in serum cholesterol levels by fucoxanthin.

Methods: Diabetic/obese KK-A(y) mice were fed a diet containing 0.2% fucoxanthin for 4 weeks. The mice were sacrificed, and total blood samples were collected for the measurement of serum total cholesterol, HDL-cholesterol and non-HDL-cholesterol levels. Cholesterol content in tissues was also analyzed. Real-time PCR and Western blotting were performed to determine hepatic mRNA and protein expression of genes involved in cholesterol metabolism, respectively.

Results: Dietary fucoxanthin significantly increased serum HDL and non-HDL cholesterol levels, and reduced hepatic cholesterol content. In liver, the expression of SREBP1, SREBP2 and their target genes involved in cholesterol biosynthesis significantly increased and tended to increase in the fucoxanthin-fed mice, respectively. In contrast, hepatic levels of LDLR and SR-B1 proteins which is important factors for LDL-cholesterol and HDL-cholesterol uptake in the liver from serum, decreased to 60% and 80% in the fucoxanthin-fed mice, respectively, compared with the control mice. Further, we found that dietary fucoxanthin significantly increased the mRNA expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), which enhances intracellular degradation of LDLR in lysosomes.

Conclusions: Fucoxanthin increased HDL-cholesterol and non-HDL-cholesterol levels in KK-A(y) mice by inducing SREBP expression and reduced cholesterol uptake in the liver via down-regulation of LDLR and SR-B1, resulted in increased serum cholesterol in the mice.

Citing Articles

Effects of Supplementation with Microalgae Extract from (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women.

Dickerson B, Maury J, Jenkins V, Nottingham K, Xing D, Gonzalez D Nutrients. 2024; 16(7).

PMID: 38613023 PMC: 11013338. DOI: 10.3390/nu16070990.

Organoid Establishment of Long-Term Culture Using Primary Mouse Hepatocytes and Evaluation of Liver Function.

Kim H, Kim Y, Kim Y, Kim Y, Ko K Prev Nutr Food Sci. 2023; 28(3):360-369.

PMID: 37842244 PMC: 10567590. DOI: 10.3746/pnf.2023.28.3.360.

Safety of an ethanolic extract of the dried biomass of the microalga as a novel food pursuant to Regulation (EU) 2015/2283.

Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst K, Maciuk A EFSA J. 2023; 21(7):e08072.

PMID: 37448447 PMC: 10336653. DOI: 10.2903/j.efsa.2023.8072.

Roles of Marine Macroalgae or Seaweeds and Their Bioactive Compounds in Combating Overweight, Obesity and Diabetes: A Comprehensive Review.

Magwaza S, Islam M Mar Drugs. 2023; 21(4).

PMID: 37103396 PMC: 10142144. DOI: 10.3390/md21040258.

How Do Brown Seaweeds Work on Biomarkers of Dyslipidemia? A Systematic Review with Meta-Analysis and Meta-Regression.

Shin D, Shim S, Wu Y, Hong G, Jeon H, Kim C Mar Drugs. 2023; 21(4).

PMID: 37103359 PMC: 10144066. DOI: 10.3390/md21040220.

References

Quintao E, Grundy S, AHRENS Jr E . Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res. 1971; 12(2):233-47. View

Beppu F, Niwano Y, Tsukui T, Hosokawa M, Miyashita K . Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice. J Toxicol Sci. 2009; 34(5):501-10. DOI: 10.2131/jts.34.501. View

Tsukui T, Konno K, Hosokawa M, Maeda H, Sashima T, Miyashita K . Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J Agric Food Chem. 2007; 55(13):5025-9. DOI: 10.1021/jf070110q. View

Rigotti A, Trigatti B, Penman M, Rayburn H, Herz J, Krieger M . A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997; 94(23):12610-5. PMC: 25055. DOI: 10.1073/pnas.94.23.12610. View

Sachindra N, Sato E, Maeda H, Hosokawa M, Niwano Y, Kohno M . Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J Agric Food Chem. 2007; 55(21):8516-22. DOI: 10.1021/jf071848a. View

Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W . NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem. 2004; 279(47):48865-75. DOI: 10.1074/jbc.M409699200. View

Brown M, Goldstein J . Biomedicine. Lowering LDL--not only how low, but how long?. Science. 2006; 311(5768):1721-3. DOI: 10.1126/science.1125884. View

Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K . Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta. 2004; 1675(1-3):113-9. DOI: 10.1016/j.bbagen.2004.08.012. View

Hosokawa M, Miyashita T, Nishikawa S, Emi S, Tsukui T, Beppu F . Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch Biochem Biophys. 2010; 504(1):17-25. DOI: 10.1016/j.abb.2010.05.031. View

10.

Zhang D, Lagace T, Garuti R, Zhao Z, McDonald M, Horton J . Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem. 2007; 282(25):18602-18612. DOI: 10.1074/jbc.M702027200. View

11.

Varban M, Rinninger F, Wang N, Dunmore J, Fang Q, GOSSELIN M . Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1998; 95(8):4619-24. PMC: 22539. DOI: 10.1073/pnas.95.8.4619. View

12.

Horton J, Shah N, Warrington J, Anderson N, Park S, Brown M . Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A. 2003; 100(21):12027-32. PMC: 218707. DOI: 10.1073/pnas.1534923100. View

13.

Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K . Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun. 2005; 332(2):392-7. DOI: 10.1016/j.bbrc.2005.05.002. View

14.

Folch J, Lees M, SLOANE STANLEY G . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1):497-509. View

15.

Rigotti A, Miettinen H, Krieger M . The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev. 2003; 24(3):357-87. DOI: 10.1210/er.2001-0037. View

16.

Brown M, Goldstein J . The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89(3):331-40. DOI: 10.1016/s0092-8674(00)80213-5. View

17.

Seidah N, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin S, Stifani S . The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A. 2003; 100(3):928-33. PMC: 298703. DOI: 10.1073/pnas.0335507100. View

18.

Attie A, Seidah N . Dual regulation of the LDL receptor--some clarity and new questions. Cell Metab. 2005; 1(5):290-2. DOI: 10.1016/j.cmet.2005.04.006. View

19.

Farkas J, Angel A, Avigan M . Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components. J Lipid Res. 1973; 14(3):344-56. View

20.

Woo M, Jeon S, Kim H, Lee M, Shin S, Shin Y . Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem Biol Interact. 2010; 186(3):316-22. DOI: 10.1016/j.cbi.2010.05.006. View